USPTO serial 99710510
VIVOPLEX
Status 641Office Action
- Filing date
- Mar 18, 2026
- Status date
- Aug 6, 2026
- Registration date
- —
- Examiner
- SNYDER, NELSON B
Need help with VIVOPLEX?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 6, 2026
Office Action issues
The USPTO found no conflicting marks, but refused the currently submitted specimen for your services because it appears to be an investor presentation slide rather than a proper source identifier.
Owner
Traverse Biotech, LLC
New York, NY, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Development of pharmaceuticals for cell and gene therapies | ACTIVE | Mar 17, 2026 |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 6, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 6, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 30, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 18, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 18, 2026 | NWAP | NEW APPLICATION ENTERED |